Go Pro

Genpact (G) Competitors

Genpact logo
$28.26 +0.76 (+2.77%)
Closing price 07/1/2026 03:59 PM Eastern
Extended Trading
$28.24 -0.02 (-0.06%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

G vs. CCRN, EXLS, GPN, BR, and JKHY

Should you buy Genpact stock or one of its competitors? MarketBeat compares Genpact with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Genpact include Cross Country Healthcare (CCRN), ExlService (EXLS), Global Payments (GPN), Broadridge Financial Solutions (BR), and Jack Henry & Associates (JKHY).

How does Genpact compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Genpact (NYSE:G) are related companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

Cross Country Healthcare presently has a consensus target price of $12.05, suggesting a potential downside of 8.71%. Genpact has a consensus target price of $43.29, suggesting a potential upside of 53.15%. Given Genpact's stronger consensus rating and higher possible upside, analysts plainly believe Genpact is more favorable than Cross Country Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90
Genpact
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 1.6% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Genpact had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for Genpact and 2 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 1.27 beat Genpact's score of 0.37 indicating that Cross Country Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Genpact has a net margin of 11.04% compared to Cross Country Healthcare's net margin of -9.84%. Genpact's return on equity of 22.70% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-9.84% -0.74% -0.54%
Genpact 11.04%22.70%10.42%

Genpact has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.05B0.40-$94.85M-$3.05N/A
Genpact$5.16B0.93$552.49M$3.268.67

Cross Country Healthcare has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, Genpact has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Summary

Genpact beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

How does Genpact compare to ExlService?

ExlService (NASDAQ:EXLS) and Genpact (NYSE:G) are both mid-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

In the previous week, ExlService had 5 more articles in the media than Genpact. MarketBeat recorded 9 mentions for ExlService and 4 mentions for Genpact. ExlService's average media sentiment score of 0.77 beat Genpact's score of 0.37 indicating that ExlService is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ExlService
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Positive
Genpact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

ExlService has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Genpact has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

ExlService has a net margin of 11.66% compared to Genpact's net margin of 11.04%. ExlService's return on equity of 28.50% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
ExlService11.66% 28.50% 15.48%
Genpact 11.04%22.70%10.42%

Genpact has higher revenue and earnings than ExlService. Genpact is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExlService$2.09B1.96$251.02M$1.5717.06
Genpact$5.16B0.93$552.49M$3.268.67

92.9% of ExlService shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 3.7% of ExlService shares are held by insiders. Comparatively, 1.6% of Genpact shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

ExlService presently has a consensus price target of $41.50, indicating a potential upside of 54.91%. Genpact has a consensus price target of $43.29, indicating a potential upside of 53.15%. Given ExlService's stronger consensus rating and higher probable upside, analysts plainly believe ExlService is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ExlService
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67
Genpact
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

Summary

ExlService beats Genpact on 12 of the 16 factors compared between the two stocks.

How does Genpact compare to Global Payments?

Global Payments (NYSE:GPN) and Genpact (NYSE:G) are both data processing & outsourced services companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

Global Payments presently has a consensus price target of $83.87, suggesting a potential upside of 11.83%. Genpact has a consensus price target of $43.29, suggesting a potential upside of 53.15%. Given Genpact's stronger consensus rating and higher probable upside, analysts plainly believe Genpact is more favorable than Global Payments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Payments
3 Sell rating(s)
18 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.08
Genpact
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

In the previous week, Global Payments and Global Payments both had 4 articles in the media. Global Payments' average media sentiment score of 0.62 beat Genpact's score of 0.37 indicating that Global Payments is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Payments
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Global Payments has higher revenue and earnings than Genpact. Global Payments is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Payments$7.71B2.66$1.40B-$2.04N/A
Genpact$5.16B0.93$552.49M$3.268.67

Genpact has a net margin of 11.04% compared to Global Payments' net margin of -7.99%. Genpact's return on equity of 22.70% beat Global Payments' return on equity.

Company Net Margins Return on Equity Return on Assets
Global Payments-7.99% 13.11% 5.79%
Genpact 11.04%22.70%10.42%

Global Payments pays an annual dividend of $1.00 per share and has a dividend yield of 1.3%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.7%. Global Payments pays out -49.0% of its earnings in the form of a dividend. Genpact pays out 23.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has raised its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

89.8% of Global Payments shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 0.6% of Global Payments shares are owned by company insiders. Comparatively, 1.6% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Global Payments has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Genpact has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Summary

Genpact beats Global Payments on 11 of the 18 factors compared between the two stocks.

How does Genpact compare to Broadridge Financial Solutions?

Broadridge Financial Solutions (NYSE:BR) and Genpact (NYSE:G) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

90.0% of Broadridge Financial Solutions shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 1.1% of Broadridge Financial Solutions shares are owned by company insiders. Comparatively, 1.6% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Broadridge Financial Solutions has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Broadridge Financial Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Broadridge Financial Solutions$6.89B2.37$839.50M$9.3415.09
Genpact$5.16B0.93$552.49M$3.268.67

Broadridge Financial Solutions presently has a consensus target price of $221.57, suggesting a potential upside of 57.22%. Genpact has a consensus target price of $43.29, suggesting a potential upside of 53.15%. Given Broadridge Financial Solutions' stronger consensus rating and higher probable upside, analysts plainly believe Broadridge Financial Solutions is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Broadridge Financial Solutions
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Genpact
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

Broadridge Financial Solutions has a net margin of 15.03% compared to Genpact's net margin of 11.04%. Broadridge Financial Solutions' return on equity of 40.14% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Broadridge Financial Solutions15.03% 40.14% 12.87%
Genpact 11.04%22.70%10.42%

Broadridge Financial Solutions has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Genpact has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Broadridge Financial Solutions pays an annual dividend of $3.90 per share and has a dividend yield of 2.8%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.7%. Broadridge Financial Solutions pays out 41.8% of its earnings in the form of a dividend. Genpact pays out 23.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Broadridge Financial Solutions has raised its dividend for 18 consecutive years and Genpact has raised its dividend for 6 consecutive years. Broadridge Financial Solutions is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Broadridge Financial Solutions had 2 more articles in the media than Genpact. MarketBeat recorded 6 mentions for Broadridge Financial Solutions and 4 mentions for Genpact. Broadridge Financial Solutions' average media sentiment score of 1.16 beat Genpact's score of 0.37 indicating that Broadridge Financial Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Broadridge Financial Solutions
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Broadridge Financial Solutions beats Genpact on 16 of the 19 factors compared between the two stocks.

How does Genpact compare to Jack Henry & Associates?

Jack Henry & Associates (NASDAQ:JKHY) and Genpact (NYSE:G) are both mid-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Genpact has higher revenue and earnings than Jack Henry & Associates. Genpact is trading at a lower price-to-earnings ratio than Jack Henry & Associates, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jack Henry & Associates$2.38B4.26$455.75M$7.1519.92
Genpact$5.16B0.93$552.49M$3.268.67

98.8% of Jack Henry & Associates shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 0.6% of Jack Henry & Associates shares are held by insiders. Comparatively, 1.6% of Genpact shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Jack Henry & Associates had 4 more articles in the media than Genpact. MarketBeat recorded 8 mentions for Jack Henry & Associates and 4 mentions for Genpact. Jack Henry & Associates' average media sentiment score of 1.12 beat Genpact's score of 0.37 indicating that Jack Henry & Associates is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jack Henry & Associates
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jack Henry & Associates has a net margin of 20.64% compared to Genpact's net margin of 11.04%. Jack Henry & Associates' return on equity of 24.03% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Jack Henry & Associates20.64% 24.03% 17.02%
Genpact 11.04%22.70%10.42%

Jack Henry & Associates presently has a consensus price target of $187.31, indicating a potential upside of 31.52%. Genpact has a consensus price target of $43.29, indicating a potential upside of 53.15%. Given Genpact's higher probable upside, analysts plainly believe Genpact is more favorable than Jack Henry & Associates.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jack Henry & Associates
0 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.79
Genpact
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

Jack Henry & Associates has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Genpact has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Jack Henry & Associates pays an annual dividend of $2.44 per share and has a dividend yield of 1.7%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.7%. Jack Henry & Associates pays out 34.1% of its earnings in the form of a dividend. Genpact pays out 23.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Jack Henry & Associates has increased its dividend for 35 consecutive years and Genpact has increased its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Jack Henry & Associates beats Genpact on 13 of the 20 factors compared between the two stocks.

Get Genpact News Delivered to You Automatically

Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

G vs. The Competition

MetricGenpactIT Services IndustryComputer SectorNYSE Exchange
Market Cap$4.66B$11.89B$39.33B$23.43B
Dividend Yield2.69%2.77%3.32%4.09%
P/E Ratio8.6745.92170.6631.21
Price / Sales0.936.51621.0621.55
Price / Cash7.2423.2948.3425.08
Price / Book1.913.299.814.81
Net Income$552.49M$534.00M$1.07B$1.07B
7 Day Performance2.28%6.97%3.63%1.43%
1 Month Performance-14.47%-10.70%-2.56%2.47%
1 Year Performance-37.18%-24.21%152.71%20.45%

Genpact Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
G
Genpact
4.848 of 5 stars
$28.26
+2.8%
$43.29
+53.2%
-37.2%$4.66B$5.16B8.67146,500
CCRN
Cross Country Healthcare
2.6407 of 5 stars
$13.21
-0.1%
$12.05
-8.8%
+0.2%$427.09M$1.05BN/A6,784
EXLS
ExlService
4.4188 of 5 stars
$25.57
-1.7%
$41.50
+62.3%
-39.9%$3.97B$2.09B16.2965,000
GPN
Global Payments
4.2675 of 5 stars
$71.22
+2.0%
$83.87
+17.8%
-8.5%$19.09B$7.71BN/A26,000
BR
Broadridge Financial Solutions
4.9277 of 5 stars
$136.16
-1.3%
$221.57
+62.7%
-42.4%$15.95B$6.89B14.5815,000

Related Companies and Tools


This page (NYSE:G) was last updated on 7/2/2026 by MarketBeat.com Staff.
From Our Partners